Rhythm Pharmaceuticals buy Wells Fargo & Company
Start price
07.04.25
/
50%
€50.50
Target price
07.04.26
€82.88
Performance (%)
89.11%
Price
23.12.25
€94.00
Summary
This prediction is currently active. The BUY prediction by Wells_Fargo___Compan for Rhythm Pharmaceuticals has seen massive gains of 89.11%. This prediction currently runs until 07.04.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rhythm Pharmaceuticals | 0.000% | 0.000% |
| iShares Core DAX® | 1.732% | 4.638% |
| iShares Nasdaq 100 | 3.304% | 0.517% |
| iShares Nikkei 225® | 2.342% | 0.972% |
| iShares S&P 500 | 2.357% | 0.872% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its price target raised by analysts at Wells Fargo & Company from $80.00 to $91.00. They now have an "overweight" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€75.50
10.07.25
10.07.25
€109.86
10.07.26
10.07.26
26.49%
23.12.25
23.12.25
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€42.40
19.12.23
19.12.23
€48.34
19.12.24
19.12.24
30.90%
20.12.24
20.12.24
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€26.00
08.11.23
08.11.23
€37.40
08.11.24
08.11.24
140.38%
09.11.24
09.11.24